C. Nolte et al., EPIDERMAL GROWTH-FACTOR IS A MOTILITY FACTOR FOR MICROGLIAL CELLS IN-VITRO - EVIDENCE FOR EGF RECEPTOR EXPRESSION, European journal of neuroscience, 9(8), 1997, pp. 1690-1698
Epidermal growth factor (EGF) and its receptor are present in the cent
ral nervous system and modulate a variety of neural functions. Here we
show that microglial cells, the brain-intrinsic macrophages, express
the receptor for EGF and migrate in response to EGF. Transcripts encod
ing the EGF receptor could be detected in purified microglial cultures
obtained from newborn mouse cortex, More specifically, cDNA fragments
derived from EGF receptor mRNA could be amplified from 21% of electro
physiologically characterized microglial cells by the use of a single-
cell reverse transcription-polymerase chain reaction method. Expressio
n of the protein was confirmed on rat microglia by flow cytometry. EGF
dose-dependently stimulated chemotactic migration, as revealed with a
microchemotaxis assay. The dose-response curve peaked at 10 ng/ml EGF
, reaching a 3-fold increase in migration over the unstimulated contro
l; migration was about half of that induced by complement 5a (10 nM),
a previously described microglial chemoattractant. Chequerboard analys
is showed that EGF-induced motility was composed of both chemotaxis an
d chemokinesis. In contrast to its pronounced effect on cell motility,
EGF (0.01-10 ng/ml) was not a mitotic signal for microglia, as shown
by lack of bromodeoxyuridine incorporation. Acute and chronic patholog
ical processes within the brain stimulate the synthesis and release of
immunoregulators and growth factors (including EGF) that play a major
role in the brain's response to injury, EGF may serve as a paracrine
factor to direct microglial cells to the lesion site, Moreover, since
EGF is secreted by activated microglia themselves in vivo, it may act
as an autocrine modulator of microglial cell function.